GLP-1 Weight Loss Treatments Gain Popularity Among Celebrities, Become More Accessible
Telehealth platforms are making GLP-1 medications, like Ozempic and Mounjaro, more accessible for weight loss, with prices starting at $99 per month.
A growing number of celebrities, including Serena Williams, Andy Cohen, and Meghan Trainor, have publicly acknowledged using GLP-1 medications such as Ozempic and Mounjaro to aid in weight loss. Serena Williams shared in July 2025 that she felt "great" and "healthy" after using Ro, a medication within the GLP-1 class. "I feel light physically and light mentally," she told People.
These treatments, once perceived as inaccessible, are now becoming more readily available through telehealth services. Arbor, a platform offering doctor-prescribed GLP-1 weight loss treatments, advertises options starting at $99 per month, with no insurance required. This initiative aims to make these medications more affordable and accessible to a wider population.
Arbor offers two main treatments. Compounded semaglutide, administered as a weekly injection, is designed to curb cravings and reduce appetite. Compounded tirzepatide, also a weekly injection, offers similar benefits at a potentially faster rate and also supports metabolism. The latter is priced at $149 per month. Both plans feature fixed pricing that does not increase with dose adjustments. The cost includes medication, dose adjustments, consultations, and check-ins, with no additional fees.
Medication is shipped via FedEx Express from a licensed pharmacy, typically arriving two days after approval. The process begins with a brief online health quiz, eliminating the need for a waitlist. Both treatment plans are eligible for HSA/FSA use, and customers can cancel at any time. Arbor also provides a 12-month money-back guarantee for unsatisfied users, supported by 24/7 physician access and registered dietitians.
The telehealth platform connects users with licensed U.S. physicians for virtual consultations, meaning in-person visits are not necessary. It's important to note that Arbor functions as a technology platform, and medical evaluations are conducted by independent licensed providers who determine treatment eligibility. Compounded medications have not undergone FDA review for safety or effectiveness, and consultation requirements can vary by state.